Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasmin N Ramadan

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Biomedicines|January 25, 2025
Editorial for Special Issue "Antibiotic Combination Therapy: A Strategy to Overcome Bacterial Resistance"Helal F Hetta, Yasmin N Ramadan, Israa M S Al-Kadmy
Clinical and Experimental Medicine|September 11, 2024
MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel diseaseYasmin N Ramadan, Ayat M Kamel, Mohammed A Medhat, et al.
Clinical and Experimental Medicine|April 5, 2025
Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systemsAhmed Aljabri, Ghareb M Soliman, Yasmin N Ramadan, et al.
World Journal of Microbiology & Biotechnology|January 30, 2026
Bacterial ghosts (BGs): A promising approach as candidate vaccineHelal F Hetta, Ibraheem M Mwafey, Noura H Abd Ellah, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Therapeutic Impact of Zanubrutinib in Chronic Lymphocytic Leukemia: Evidence from a Systematic Review and Single-Arm Meta-AnalysisYasser Alatawi, Fawaz E Alanazi, Abdullah Alattar, et al.
World Journal of Methodology|June 23, 2025
Gut virome: New key players in the pathogenesis of inflammatory bowel diseaseHelal F Hetta, Rehab Ahmed, Yasmin N Ramadan, et al.
Infection|February 21, 2026
Targeting antimicrobial resistance through vaccinology: a review of preclinical and clinical pipeline vaccines against WHO priority bacterial pathogensHelal F Hetta, Zinab Alatawi, Salwa Q Bukhari, et al.
Pathogens (Basel, Switzerland)|August 25, 2023
Nanotechnology-Based Strategies to Combat Multidrug-Resistant <i>Candida auris</i> InfectionsHelal F Hetta, Yasmin N Ramadan, Israa M S Al-Kadmy, et al.
Molecular Neurobiology|April 15, 2025
Microbiome Gut-Brain-Axis: Impact on Brain Development and Mental HealthYasmin N Ramadan, Saleh F Alqifari, Khaled Alshehri, et al.
Molecular Neurobiology|November 29, 2025
The Gut-Brain Axis in Autism: Inflammatory Mechanisms, Molecular Insights, and Emerging Microbiome-Based TherapiesHelal F Hetta, Fawaz E Alanazi, Saleh F Alqifari, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Biomedicines|January 25, 2025
Editorial for Special Issue "Antibiotic Combination Therapy: A Strategy to Overcome Bacterial Resistance"Helal F Hetta, Yasmin N Ramadan, Israa M S Al-Kadmy
Clinical and Experimental Medicine|September 11, 2024
MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel diseaseYasmin N Ramadan, Ayat M Kamel, Mohammed A Medhat, et al.
Clinical and Experimental Medicine|April 5, 2025
Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systemsAhmed Aljabri, Ghareb M Soliman, Yasmin N Ramadan, et al.
World Journal of Microbiology & Biotechnology|January 30, 2026
Bacterial ghosts (BGs): A promising approach as candidate vaccineHelal F Hetta, Ibraheem M Mwafey, Noura H Abd Ellah, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Therapeutic Impact of Zanubrutinib in Chronic Lymphocytic Leukemia: Evidence from a Systematic Review and Single-Arm Meta-AnalysisYasser Alatawi, Fawaz E Alanazi, Abdullah Alattar, et al.
World Journal of Methodology|June 23, 2025
Gut virome: New key players in the pathogenesis of inflammatory bowel diseaseHelal F Hetta, Rehab Ahmed, Yasmin N Ramadan, et al.
Infection|February 21, 2026
Targeting antimicrobial resistance through vaccinology: a review of preclinical and clinical pipeline vaccines against WHO priority bacterial pathogensHelal F Hetta, Zinab Alatawi, Salwa Q Bukhari, et al.
Pathogens (Basel, Switzerland)|August 25, 2023
Nanotechnology-Based Strategies to Combat Multidrug-Resistant <i>Candida auris</i> InfectionsHelal F Hetta, Yasmin N Ramadan, Israa M S Al-Kadmy, et al.
Molecular Neurobiology|April 15, 2025
Microbiome Gut-Brain-Axis: Impact on Brain Development and Mental HealthYasmin N Ramadan, Saleh F Alqifari, Khaled Alshehri, et al.
Molecular Neurobiology|November 29, 2025
The Gut-Brain Axis in Autism: Inflammatory Mechanisms, Molecular Insights, and Emerging Microbiome-Based TherapiesHelal F Hetta, Fawaz E Alanazi, Saleh F Alqifari, et al.
Pageof 3